Please assess the completion status of the following clinical trial:

Trial Title: Metabolomic Profiling of Novel Mediators of Vascular Function

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Adults age 18 or older~* Type 2 diabetes mellitus~Exclusion Criteria:~* Type 1 diabetes mellitus~* Type 2 diabetics taking insulin, thiazolidinediones (rosiglitazone or pioglitazone), an amylin analog (Symlin \[pramlintide\]), or incretin mimetics (Byetta \[exenatide\])~* Pregnancy~* Uncontrolled hypertension, \> 180/100 mmHg

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- 1 (Type: None): Blood sampling and brachial artery ultrasound

Based on this trial design, predict the completion outcome and termination type (if applicable).